Most Popular
-
1
Korea’s homegrown nanosatellite successfully launches into space
-
2
[Herald Interview] 'Amid aging population, Korea to invite more young professionals from overseas'
![[Herald Interview] 'Amid aging population, Korea to invite more young professionals from overseas'](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/24/20240424050844_0.jpg&u=20240424200058)
-
3
Ador CEO denies allegations, accuses Hybe of mistreating NewJeans
-
4
Nicaragua shuts down Seoul embassy
-
5
Hybe's multilabel system tested amid conflict with Ador
![[Herald Interview] 'Amid aging population, Korea to invite more young professionals from overseas'](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/24/20240424050844_0.jpg&u=20240424200058)
-
6
Rocket engine expert, ex-NASA exec to lead Korea's new space agency
-
7
SNU profs to suspend treatment for one day
-
8
SK hynix pledges W20tr to ramp up DRAM production at home
-
9
Over-50s, men, single-person households take up majority of those filing for bankruptcy
-
10
Pianist Cho Seong-Jin named Berlin Philharmonic's artist-in-residence
SK Chemical to release first cell culture quadrivalent flu vaccine
By 황유미Published : Aug. 11, 2016 - 08:03
[THE INVESTOR] SK Chemical is releasing a flu vaccine, the first cell culture vaccine that covers four strains of influenza viruses, next month. A total of 5 million units have been manufactured, it announced on Aug. 10.
Dubbed SKY Cell Flu Quadrivalent, “it is a next generation vaccine that can prevent four kinds of viruses with a single vaccination,” the company said.
Dubbed SKY Cell Flu Quadrivalent, “it is a next generation vaccine that can prevent four kinds of viruses with a single vaccination,” the company said.
[
Multinational firm Glaxo Smith Kline already sells its own quadrivalent, that covers two influenza A strains (H1N1, H3N2) and two influenza B strains (Yamagata, Victoria).
SK Chemical’s vaccine, however, is the first to be manufactured by a cell culture method, which stabilizes and accelerates the manufacturing process, according to the company. It also is free from the possible allergic reactions to egg protein, as it uses aseptic culture medium instead of eggs used in traditional method.
By Hwang You-mee (glamazon@heraldcorp.com)
Multinational firm Glaxo Smith Kline already sells its own quadrivalent, that covers two influenza A strains (H1N1, H3N2) and two influenza B strains (Yamagata, Victoria).
SK Chemical’s vaccine, however, is the first to be manufactured by a cell culture method, which stabilizes and accelerates the manufacturing process, according to the company. It also is free from the possible allergic reactions to egg protein, as it uses aseptic culture medium instead of eggs used in traditional method.
By Hwang You-mee (glamazon@heraldcorp.com)
![[KH Explains] Korean shipbuilding stocks rally: Real growth or bubble?](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=652&simg=/content/image/2024/04/25/20240425050656_0.jpg&u=)
